Application of hemp seed composition in preparation of medicine for treating hashimoto thyroiditis
Through the preparation of the mascia kernel composition, TgAb-induced thyroid follicular cell damage was alleviated, and the problem of lack of etiology and universality of traditional Chinese medicine prescriptions was solved.
Patent Information
- Application Number
- CN202411218912.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-12-03
AI Technical Summary
The prior art lacks effective methods for the treatment of Hashimoto's thyroiditis, and there are problems of excessive syndrome differentiation and differences in combination with prescriptions, which cannot provide a universal basis.
Using the macadamia kernel composition, including macadamia kernel, peony, citrus aurantium, rhubarb, Magnolia officinalis and almonds, a raw drug concentration of 180-220μg/ml is prepared by decoction and concentration, which is used to alleviate the thyroid follicular cells induced by TgAb. Injuries such as proliferation inhibition, apoptosis and overexpression of inflammatory factors.
The mascia kernel composition significantly protects thyroid follicular cells, reduces cell apoptosis, increases thyroxine T4 levels, and reduces the expression of the inflammatory factor IL-6, providing new treatment ideas for Hashimoto's thyroiditis and the direction of traditional Chinese medicine development.
Smart Images

Figure CN119055707A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to application of a hemp seed composition in preparing a medicine for treating Hashimoto's thyroiditis. Background Art
[0002] Hashimoto thyroiditis (HT) is an autoimmune thyroid disease characterized by lymphocyte infiltration. The disease was first described by Japanese physician Hakaru Hashimoto in 1912 and was subsequently discovered between 1931 and 1957. Currently, the etiology of HT is not fully understood, but can be summarized into the following categories: (1) viral infection; (2) abnormal nutrient intake, such as selenium deficiency, iodine deficiency, and excessive iodine intake; (3) genetic factors and social environment.
[0003] Thyroglobulin antibodies (TgAb) and thyroid peroxidase antibodies (TPOAb) are the main thyroid autoantibodies against thyroglobulin (Tg) and thyroid peroxidase (TPO) antigens, respectively. High titers of TgAb and TPOAb in serum are the standard basis for the clinical diagnosis of HT.
[0004] At present, Western medicine has no treatment for the cause of Hashimoto's thyroiditis. In the early stage of clinical treatment, most of them advocate the use of Western medicine such as antithyroid drugs and glucocorticoids. Those who cannot adhere to medication can be treated with artificial radionuclide I-131. In the middle and late stages, surgical treatment such as laparoscopic thyroid surgery is usually adopted. However, there are problems such as adverse drug reactions, liver damage that can easily be caused by achieving control effects, and slightly higher costs for laparoscopic thyroid surgery. In terms of the diagnosis and treatment of clinical diseases, traditional Chinese medicine has definite efficacy and few toxic and side effects, and is easily accepted by patients. Despite this, traditional Chinese medicine still has practical problems such as too many syndrome differentiations and differences in compatibility and composition, and cannot provide a universal basis for guiding the use of drugs for HT in clinical practice.
[0005] Therefore, it is urgent to clarify the role of TgAb in the onset of HT, carry out experimental basic research at the same time, with the goal of discovering more effective Chinese medicines for the treatment of HT, provide new ideas for the development of Chinese medicines for HT, and give full play to the characteristics of traditional Chinese medicine. Summary of the invention
[0006] In view of this, the purpose of the present invention is to provide an application of a hemp seed composition in the preparation of a drug for treating Hashimoto's thyroiditis, wherein the hemp seed composition can alleviate TgAb-induced thyroid follicular cell proliferation inhibition, apoptosis, cell migration and overexpression of inflammatory factors and other damages, and can regulate T4 secretion levels. The above research findings provide new ideas for the later treatment of HT.
[0007] To achieve the above object, the present invention provides the following technical solutions:
[0008] The invention provides application of a hemp seed composition in preparing a medicine for treating Hashimoto's thyroiditis.
[0009] Preferably, the sesame seed composition comprises the following raw material components in parts by weight:
[0010] 20-25 parts of hemp seed kernel, 10-15 parts of peony root, 10-15 parts of immature bitter orange, 25-30 parts of rhubarb, 1-5 parts of magnolia bark, and 10-15 parts of apricot kernel.
[0011] Preferably, the crude drug concentration of the sesame seed composition is 180-220 μg / ml.
[0012] Preferably, the preparation method of the sesame seed composition comprises the following steps:
[0013] (1) mixing hemp seed, peony root, immature bitter orange, rhubarb, magnolia bark and apricot kernel with water, soaking, decocting, and obtaining a decoction 1 and a medicinal residue;
[0014] (2) decocting the medicinal residue for a second time to obtain decoction 2;
[0015] (3) combining decoction 1 and decoction 2, concentrating, vacuum drying, freezing, and freeze-drying to obtain a sesame seed composition.
[0016] Preferably, the amount of water used in step (1) is 7.5 to 10 times the amount of water used for soaking the medicinal materials.
[0017] Preferably, the solvent for the secondary decoction in step (2) is water, and the amount of water used is 2 to 3 times the mass of the medicinal residue.
[0018] Preferably, the concentration time in step (3) is based on obtaining 50 to 70 ml of concentrated solution.
[0019] Preferably, the freezing temperature in step (3) is -70 to -80°C, and the freezing time is 10 to 15 hours.
[0020] Preferably, the freeze-drying temperature in step (3) is -60 to -70°C, and the freeze-drying time is 36 to 48 hours.
[0021] The invention also provides application of the hemp seed composition in preparing medicine for treating thyroid cell damage.
[0022] Compared with the prior art, the present invention has the following beneficial effects:
[0023] The present invention establishes a model study of TgAb-induced human thyroid follicular cell damage based on in vitro cell culture, the purpose of which is to confirm that TgAb is the main pathogenic factor of Hashimoto's thyroiditis, preliminarily explore the mechanism of action of TgAb on HT, and find out the effective prescription for treating HT in "Treatise on Febrile and Miscellaneous Diseases" to explore it. The sesame seed composition has a significant protective effect on the thyroid follicular cell damage model, can reduce the occurrence of cell apoptosis, increase the level of thyroxine T4, reduce the expression of inflammatory factor IL-6 and the large-area migration of inflammatory tissue.
[0024] Through the MTT colorimetric method, it was found that the cell viability of the model drug administration group was higher than that of the model control group, and lower than that of the blank control group; the cell viability of the model drug administration group was basically significantly higher than that of the blank drug administration group. From the dose-effect relationship, the protective effect of Ma Zi Ren Wan on the cell injury model first increased and then decreased with the increase of drug concentration. Through the experimental results of cell apoptosis, it was found that the cell apoptosis rate of the model drug administration group was lower than that of the model control group, and the Ma Zi Ren composition had a significant effect on inhibiting cell apoptosis. In the cell scratch experiment, the cell migration rate of the model drug administration group was lower than that of the model control group. Through ELISA detection, it was found that the supernatant content of T4 in the model drug administration group was higher than that in the model control group, while the expression level of the inflammatory factor IL-6 in the model drug administration group was lower than that in the model control group.
[0025] TgAb inhibits the growth and proliferation of thyroid follicular cells and the ability of cell migration, and significantly reduces cell viability and apoptosis rate. Maziren Pills selected from Treatise on Febrile and Miscellaneous Diseases can alleviate TgAb-induced damage to Nthy-ori3-1 cell proliferation inhibition, apoptosis, cell migration and overexpression of inflammatory factors, and regulate T4 secretion levels. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The dose-effect relationship of different concentrations of TgAb on the damage rate of Nthy-ori 3-1 cells;
[0027] Figure 2 is the time-effect relationship between TgAb and the injury rate of Nthy-ori 3-1 cell model, where “****” represents P < 0.0001;
[0028] Figure 3 The cell migration rate results in Example 5, where “**” represents P < 0.05;
[0029] Figure 4 The cell migration rate results after 0 h of culture in Example 5, wherein the left picture is an inverted phase contrast microscope picture of the control group, and the right picture is an inverted phase contrast microscope picture of the model group;
[0030] Figure 5The cell migration rate results after 24 hours of culture in Example 5, wherein the left picture is an inverted phase contrast microscope picture of the control group, and the right picture is an inverted phase contrast microscope picture of the model group;
[0031] Figure 6 The cell morphology of Example 6 was observed by an inverted phase contrast microscope at a magnification of 200 times, wherein the left picture is the blank group and the right picture is the model group;
[0032] Figure 7 The cell morphology of Example 6 was observed by an inverted phase contrast microscope at a magnification of 400 times, wherein the left picture is the blank group and the right picture is the model group;
[0033] Figure 8 The results of cell apoptosis rate detected by flow cytometry in Example 7;
[0034] Fig. 9 This is a map of the antigen-antibody binding position detected after infection with DAPI in Example 8, wherein the left picture is the blank group and the right picture is the model group;
[0035] Fig.10 This is a map of the antigen-antibody binding position detected after FITC infection in Example 8, wherein the left picture is the blank group and the right picture is the model group;
[0036] Fig.11 for Fig. 9 and Fig.10 Merged position map of the results;
[0037] Fig.12 The results of the T4 and IL-6 levels detected in Example 9 are shown in FIG. 9 , wherein ** represents P < 0.05;
[0038] Fig.13 The results are the protection rates of hemp seed compositions with different crude drug concentrations on different cell states;
[0039] Fig.14 is the result of the cell migration rate measured in Example 13;
[0040] Fig.15 The results of the effect of the hemp seed composition on the migration ability of thyroid follicular epithelial cells observed by inverted phase contrast microscopy in Example 13 are shown in FIG. 13; wherein, from left to right are the results of the blank control group, the results before adding the hemp seed composition (model control group), and the results after adding the hemp seed composition (model administration group);
[0041] Fig.16The cell morphology diagrams are observed after 200 times magnification using an inverted phase contrast microscope in Example 14, wherein the left diagram is a cell morphology diagram of the blank control group, and the right diagram is a cell morphology diagram of the model control group;
[0042] Fig.17 The cell morphology diagrams are observed after 400 times magnification using an inverted phase contrast microscope in Example 14, wherein the left diagram is a cell morphology diagram of the blank control group, and the right diagram is a cell morphology diagram of the model control group;
[0043] Fig.18 The cell morphology images observed after 200 times magnification using an inverted phase contrast microscope in Example 14, wherein the left image is the cell morphology image of the blank administration group, and the right image is the cell morphology image of the model administration group;
[0044] Fig.19 The figure is a diagram of cell apoptosis detected by flow cytometry in Example 15, wherein the left figure is the result of the blank group, and the right figure is the result of the model group;
[0045] Fig. 20 This is a diagram showing the cell apoptosis in the model drug administration group detected by flow cytometry in Example 15;
[0046] Fig.21 The apoptosis rate results obtained by analyzing Example 15;
[0047] Fig. 22 These are the results of T4 and IL-6 content in the cell supernatants of different groups obtained by ELISA detection in Example 16. DETAILED DESCRIPTION
[0048] The invention provides application of a hemp seed composition in preparing a medicine for treating Hashimoto's thyroiditis.
[0049] In the present invention, the sesame seed composition preferably includes the following raw material components in parts by weight: 20-25 parts of sesame seed, 10-15 parts of peony, 10-15 parts of immature bitter orange, 25-30 parts of rhubarb, 1-5 parts of magnolia bark, and 10-15 parts of apricot kernel. In the present invention, the hemp seed composition includes 20-25 parts of hemp seed, preferably 21-24 parts, and more preferably 22-23 parts; the hemp seed composition includes 10-15 parts of peony, preferably 11-14 parts, and more preferably 12-13 parts; the hemp seed composition includes 10-15 parts of immature bitter orange, preferably 11-14 parts, and more preferably 12-13 parts; the hemp seed composition includes 25-30 parts of rhubarb, preferably 26-28 parts, and more preferably 27 parts; the hemp seed composition includes 1-5 parts of magnolia bark, preferably 2-4 parts, and more preferably 3 parts; the hemp seed composition includes 10-15 parts of apricot kernel, preferably 11-14 parts, and more preferably 12-13 parts. The hemp seed composition is mainly used to treat constipation caused by dryness and heat in the stomach and intestines. The stomach has dryness and heat, and now the stomach is strong and the spleen is weak, the spleen fluid is insufficient and the intestines lose moisture, so the prescription has the functions of moistening the intestines, purging heat, and promoting qi and relieving constipation. The spleen is responsible for the circulation of body fluids for the stomach. The syndrome corresponding to Maziren Pills is called "Spleen Deficiency" in Treatise on Febrile Diseases. The prescription includes Maziren, Zhishi, Magnolia officinalis, Rhubarb, Apricot Kernel, and Peony Root. Maziren in the prescription is sweet and mild in nature, moist and fatty, and can moisten the intestines and relieve constipation, so it is the main medicine; Apricot Kernel can clear the lung qi and moisten the large intestine, while White Peony Root can nourish blood and restrain Yin, relieve urgency and stop pain, and these two are the ministers; Rhubarb, Zhishi, and Magnolia officinalis are Xiaochengqi Decoction, which can relieve heat and eliminate dryness and heat in the stomach and intestines. Honey is sweet and mild, which can not only help Maziren moisten the intestines and relieve constipation, but also relieve the attacking power of Xiaochengqi Decoction, so it is the assistant.
[0050] In the present invention, the crude drug concentration of the hemp seed composition is preferably 180 to 220 μg / ml, more preferably 190 to 210 μg / ml, and even more preferably 200 μg / ml.
[0051] In the present invention, the preparation method of the sesame seed composition preferably comprises the following steps:
[0052] (1) mixing hemp seed, peony root, immature bitter orange, rhubarb, magnolia bark and apricot kernel with water, soaking, decocting, and obtaining a decoction 1 and a medicinal residue;
[0053] (2) decocting the medicinal residue for a second time to obtain decoction 2;
[0054] (3) combining decoction 1 and decoction 2, concentrating, vacuum drying, freezing, and freeze-drying to obtain a sesame seed composition.
[0055] In the present invention, hemp seed, peony root, immature bitter orange, rhubarb, magnolia bark and apricot kernel are mixed with water, soaked and decocted to obtain a decoction 1 and medicinal residues.
[0056] In the present invention, the amount of water is preferably 7.5 to 10 times the amount of the soaked medicinal material, more preferably 8 to 9.5 times the amount of the soaked medicinal material, and further preferably 8.5 to 9 times; the soaking time is preferably 20 to 40 minutes, more preferably 25 to 35 minutes, and further preferably 30 minutes; the decoction temperature is preferably 120 to 250°C, more preferably 150 to 230°C, more preferably 180 to 240°C, and further preferably 200 to 220°C; the decoction time is preferably 50 to 70 minutes, more preferably 55 to 65 minutes, and further preferably 60 minutes.
[0057] In the present invention, the medicinal residue is decocted twice to obtain decoction 2.
[0058] In the present invention, the solvent for the secondary decoction is preferably water, and the amount of water is preferably 2 to 3 times the mass of the medicinal residue, more preferably 2.2 to 2.8 times, more preferably 2.4 to 2.6 times, and even more preferably 2.5 times; the purpose of the secondary decoction is to precipitate the remaining effective ingredients of the Chinese herbal medicine slices as much as possible.
[0059] In the present invention, decoction liquid 1 and decoction liquid 2 are combined, concentrated, vacuum dried, frozen, and freeze-dried to obtain a sesame seed composition.
[0060] In the present invention, the concentration time is preferably based on obtaining 50-70 ml of concentrated solution, further preferably based on obtaining 55-65 ml of concentrated solution, and further preferably based on obtaining 60 ml of concentrated solution; the concentration temperature is preferably 80-90°C, further preferably 82-88°C, further preferably 84-86°C, and further preferably 85°C; after the concentration, negative pressure suction impurity removal treatment and centrifugation treatment are preferably performed; the centrifugal temperature is preferably 20-30°C, further preferably 22-28°C, and further preferably 24-26°C; the centrifugal speed is preferably 2500-3500r / min, further preferably 2600-3200r / min, and further preferably 2800-3000r / min; the centrifugal time is preferably 20-30min, further preferably 22-28min, and further preferably 24-26min; the vacuum drying temperature is preferably 56-58°C, The preferred embodiment is 57°C; the vacuum drying pressure is preferably -0.090 to -0.095MPa, further preferably -0.092 to -0.094MPa, and further preferably -0.093MPa; the vacuum drying time is preferably 20 to 30h, further preferably 22 to 28h, and further preferably 24 to 26h; the freezing temperature is preferably -70 to -80°C, further preferably -72 to -78°C, further preferably -74 to -76°C, and further preferably -75°C; the freezing time is preferably 10 to 15h, further preferably 12 to 14h, and further preferably 13h; the freeze-drying temperature is preferably -60 to -70°C, further preferably -62 to -68°C, further preferably -64 to -66°C, and further preferably -65°C; the freeze-drying time is preferably 36 to 48h, further preferably 40 to 45h, and further preferably 42 to 44h.
[0061] The invention also provides application of the hemp seed composition in preparing medicine for treating thyroid cell damage.
[0062] In the present invention, the thyroid cells are thyroid follicular epithelial cells.
[0063] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0064] Example 1 Cell culture
[0065] 1.1 Rapidly take out the cryotube containing 1ml Nthy-ori 3-1 cell suspension (purchased from Guangzhou Jinio Biotechnology Co., Ltd.) from the liquid nitrogen tank, thaw it in a 37℃ water bath, wipe the surface of the cryotube with alcohol and move it to the clean bench, pipette the cell suspension into a 15ml centrifuge tube, add 10ml RPMI-1640 culture medium (purchased from Gibco, USA), blow and mix, centrifuge at 1000r / min for 10min, discard the supernatant, add 9ml RPMI-1640 culture medium and blow evenly, add 1ml FBS, move the cell suspension into a cell culture dish (purchased from Corning, USA), and place it in a 37℃ constant temperature cell culture incubator for recovery culture. After 1 day, observe the cell growth and change the medium. Place the cell culture dish on a clean bench and shake it crosswise to remove the cells that were not firmly attached to the wall. Aspirate the original culture medium and add 10 ml of RPMI-1640 culture medium in two equal amounts. After shaking and washing, add 10 ml of complete culture medium containing 15% FBS and place in an incubator for culture.
[0066] 1.2 The Nthy-ori 3-1 cells cultured in 1.1 were subjected to routine cell passaging procedures and 1×10 6 The cells were added to 20 ml of RPMI-1640 medium containing 10% fetal bovine serum (purchased from Gibco, USA). After the cell solution was evenly pipetted, it was transferred to the sample loading tank. Then, 200 μl of 1×10 4 The cell culture medium of cells was added to the 96-well plate, and the plate was placed in a carbon dioxide cell culture incubator for 24 hours to observe the cell growth. The next day, the 96-well plate was washed twice with 210 μl / well PBS to avoid interference with the experiment caused by low-level antibodies contained in the complete culture medium.
[0067] Example 2 Establishment of TgAb-induced thyroid follicular epithelial cell injury model
[0068] The 96-well plate treated in part 1.2 of Example 1 was divided into two groups, namely a model group and a control group, wherein the treatment method of the model group was: adding a TgAb working solution with a concentration of 8 ng / ml obtained by diluting the RPMI-1640 medium in a manner of 200 μl / well; the treatment method of the control group was: adding the same volume of basic medium as the model group, that is, the cells grew under normal conditions. After the model group and the control group were treated respectively, the 96-well plate was placed in an incubator for continued culture. Three sets of duplicate wells were set for the model group and the control group respectively.
[0069] Example 3 MTT experiment
[0070] The 96-well plate treated in part 1.2 of Example 1 was divided into two groups, namely a model group and a control group. In the model group, 200 μl of RPMI-1640 culture medium containing TgAb at different concentrations (antibody concentrations were 1, 2, 4, 8, 16, and 32 ng / ml) was added, and the plate was placed in a carbon dioxide constant temperature incubator for 24 hours. On the second day, the cells in the wells were observed and the supernatant was removed. 100 μl of the pre-prepared 10% MTT working solution (Sigma, USA) was added to each well with a spray gun. After incubation in a constant temperature incubator for 3.5 hours, the supernatant was removed, 150 μl of DMSO solution (purchased from Beijing Solebow Technology Co., Ltd.) was added to each well, and the plate was moved to a horizontal shaker and shaken for 20 minutes to completely dissolve the crystal violet. The absorbance OD value at 570 nm was measured with an enzyme marker to calculate the cell damage rate. The experiment was repeated 3 times. The results are shown in Tables 1 and Figure 1 shown.
[0071] The formula for calculating the cell injury rate is: cell injury rate = (blank group OD value - model group OD value) / blank group OD value × 100%.
[0072] Table 1 The dose-effect relationship of different TgAb concentrations on Nthy-ori 3-1 cell damage
[0073]
[0074] As shown in Table 1, the damage rate of thyroid follicular epithelial cells increased with the increase of TgAb concentration, showing a dose-effect dependence. When the concentration of TgAb solution was 8 ng / ml, the cell damage effect reached a plateau.
[0075] Example 4 MTT experiment
[0076] The experiment was carried out according to the method in Example 3, except that only the RPMI-1640 medium containing TgAb at a plateau concentration of 8 ng / ml was used as the model group for the MTT experiment. The damage rate of thyroid follicular epithelial cells was detected at 6, 12, 24, 36, and 48 hours of culture. The results are shown in Table 2 and Figure 2 shown.
[0077] Table 2 Time-dependent relationship between TgAb and damage rate of Nthy-ori 3-1 cell model
[0078]
[0079]
[0080] The results showed that TgAb tended to be stable after 24 hours of action on the thyroid follicular epithelial cell model, and the difference between the model group and the control group was statistically significant, P<0.0001.
[0081] Example 5 Cell scratch assay
[0082] Use a marker to mark two parallel lines on the bottom of each well of a 6-well plate to divide the bottom diameter equally. Nthy-ori 3-1 cells cultured normally in Example 1 were passaged at 1×10 6 cells / well were inoculated into 6-well plates and cultured for 24 h to ensure that the cells covered 90% of the bottom of the dish. Each well was scratched with a 200 μl pipette tip, and the tip was evenly moved perpendicular to the thin line marked on the bottom of the dish. Each well was scratched twice. After scratching, the plates were washed twice with PBS to wash away the cells that fell off after mechanical damage.
[0083] A control group and a model group were set up in a 6-well plate, wherein 1 ml of RPMI-1640 medium was added to the control group, and 1 ml of RPMI-1640 medium containing 8 ng / ml TgAb was added to the model group; the plates were cultured in a carbon dioxide constant temperature incubator, and cell growth was observed and photographed at 0 and 24 hours of culture, respectively, to ensure that the photographing position at each time point was the same scratch site. Image J software was used to analyze and calculate the cell migration rate. The calculation formula for the cell migration rate is: cell migration rate = (initial area - 24h area) / initial area × 100%. The results are shown in Figure 3 , Figure 4 and Figure 5 shown.
[0084] Depend on Figure 3-5 It can be seen that the scratch healing rate of the control group was 67.37% ± 0.025, and the scratch healing rate of the model group was 36.49% ± 0.021. Compared with the control group, the scratch healing rate of the model group was significantly reduced, and the difference was statistically significant P < 0.01. This result shows that TgAb can inhibit cell growth and tissue healing.
[0085] Example 6 Observation of cell morphology using an inverted phase contrast microscope
[0086] The Nthy-ori 3-1 cells in the logarithmic growth phase in Example 1 were digested with 0.25% EDTA-containing trypsin solution (purchased from Sigma, USA). After counting the cells, the cells were diluted to a cell density of 5×10 5 After preparing a cell suspension of 50 cells / ml, the cells were inoculated into a 6-well plate and incubated in a carbon dioxide constant temperature incubator for 24 h. The supernatant in the plate was aspirated and the plate was washed twice with PBS solution.
[0087] A blank group and a model group were set up in a 6-well plate. 1 ml / well of basic culture medium was added to the blank group; 1 ml / well of TgAb working solution diluted with basic culture medium to a concentration of 8 ng / ml was added to the model group. The 6-well plates of the blank group and the model group were placed in a constant temperature incubator and cultured for 24 hours. The morphological changes of cells in each group were observed under an inverted phase contrast microscope and photographed and recorded. The results are shown in Figure 6 and Figure 7 shown.
[0088] It was observed that the thyroid follicular cells in the blank group were mostly cubic, with smooth and intact cell membranes, clear boundaries, transparent cytoplasm, good adhesion to the wall, and normal nuclear division under a high-power microscope; while the thyroid follicular cells in the model group were cubic, oval or irregular, with blurred cell boundaries, less cytoplasm, poor adhesion to the wall, and cell vacuolation.
[0089] Example 7 Flow cytometry experiment
[0090] The cells cultured in Section 1.1 of Example 1 were centrifuged and counted, and 1 ml containing 1×10 6 Add the cell suspension of cells to each well of a 6-well plate, add 100 μl of fetal bovine serum, shake gently, incubate in a constant temperature incubator for 24 hours, observe the cells, and wash with PBS by shaking. Set up a blank group and a model group in the 6-well plate, where 1 ml of serum-free RPMI-1640 medium was added to the blank group; an equal amount of serum-free RPMI-1640 medium containing TgAb at a concentration of 8 ng / ml was added to the model group. Transfer the 6-well plate to an incubator and culture for 24 hours.
[0091] Subsequent experiments were performed according to the instructions of the AnnexinV-FITC / PI apoptosis detection kit (purchased from Hangzhou Lianke Biotechnology Co., Ltd.). Specifically, the cells were washed once with PBS, digested with 0.8 ml of EDTA-free trypsin digestion solution (EDTA may affect the binding of AnnexinV to phosphatidylserine), digestion was terminated, the cells were gently blown and centrifuged at 2000 r / min for 5 min, the cells were collected, the supernatant was discarded, the cells were resuspended twice with 4 ml of pre-cooled PBS, counted, and 1-10×10 5 cells, centrifuge again and discard the supernatant, resuspend each group of cells in 500 μl of 1× Binding Buffer in a flow tube, add 5 μl of Annexin V-FITC dye to the flow tube, store at room temperature in the dark for 5 min after resuspending, add 10 μl of PI, gently flick to mix, incubate at room temperature in the dark for 5 min, and detect cell apoptosis rate by flow cytometry within 1 h. The results are shown in Table 3 and Figure 8 shown.
[0092] Table 3 Damage rate of TgAb at a concentration of 8 ng / ml on the cell model detected by flow cytometry double staining
[0093]
[0094] The results showed that compared with the blank group without TgAb treatment, the apoptosis rate of Nthy-ori 3-1 cells in the model group was significantly increased, indicating that TgAb promoted the apoptosis process of thyroid follicular epithelial cells and induced apoptotic damage.
[0095] Example 8 Indirect Immunofluorescence
[0096] After subculturing the Nthy-ori 3-1 cells in the logarithmic growth phase in Section 1.1 of Example 1, 2×10 4 The cell suspension of cells was dropped on a clean coverslip of 24×24 mm, placed in a 6-well plate, and cultured in a constant temperature incubator for 24 h to allow the cells to grow well. The supernatant was aspirated, and the cells were washed twice with PBS. 1 ml of tissue fixative (purchased from Wuhan Boster Biotechnology Co., Ltd.) was added to each experimental well of the six-well plate, and the cells were fixed for 10 min and then aspirated. After washing twice with PBS, ready-to-use normal rabbit serum (purchased from Wuhan Boster Biotechnology Co., Ltd.) was fully added, and the cells were blocked at 25°C for 30 min.
[0097] A blank group and a model group were set up in a 6-well plate. 1 ml of PBS solution was added to the wells of the blank group, and 1 ml of TgAb working solution (8 ng / ml) was added to the wells of the model group, and cultured overnight at 4°C. The next day, the 6-well plate was placed on a decolorizing shaker and the slides were washed 3 times with PBS solution, 5 minutes each time. After slightly drying, FITC-labeled rabbit anti-goat IgG antibody (purchased from Beijing Zhongshan Jinqiao Biotechnology Co., Ltd.) was added to the slides, covered, and incubated at room temperature for 50 minutes. Wash with PBS 3 times, 5 minutes / time, and after absorbing the excess liquid, DAPI staining solution (purchased from Wuhan Boster Biotechnology Co., Ltd.) was added to the cell slides, incubated at 25°C in the dark for 10 minutes, and the cell well plate was placed on a decolorizing shaker, and the slides were washed 3 times with PBS solution, 5 minutes each time. The cell slides were taken out of the 6-well plate, slightly dried, and sealed with PBS sealing medium (purchased from Wuhan Boster Biotechnology Co., Ltd.), and then placed on a fluorescence microscope for observation under the microscope and collection and photography. The results are as follows Fig. 9 , Fig.10 , Fig.11 shown.
[0098] Among them, the cell nucleus stained with DAPI appears blue under ultraviolet excitation, and the positively expressed FITC fluorescent marker emits green light.
[0099] Figure 9-11The results showed that Tg antigen was expressed in the colloid of thyroid follicular cells, and the fluorescence signal labeled by FITC in the blank group was lower than that in the model group, indicating that TgAb promoted the production and secretion of Tg in thyroid follicular cells, and there was specific binding of Tg and TgAb during in vitro cell culture.
[0100] Example 9 Enzyme-linked immunosorbent assay
[0101] After the Nthy-ori 3-1 cells in Example 1 were subcultured, Nthy-ori 3-1 cells were cultured at 1×10 6 cells / well were added to a 6-well plate, and 100 μl of fetal bovine serum was added. After gently shaking the 6-well plate, the plate was placed in a constant temperature incubator for 24 h and the cells were observed; the plates were washed by shaking with PBS.
[0102] A blank group and a model group were set up in a 6-well plate. 1 ml of RPMI-1640 medium without serum was added to the blank group; an equal amount of RPMI-1640 medium containing 8 ng / ml TgAb was added to the model group; the 6-well plate was transferred to an incubator and cultured for 24 hours. The cell supernatant was taken and transferred to a 2 ml EP tube, centrifuged at 4 °C and 2500 r / min for 20 minutes, and the supernatant was aspirated into a new spare EP tube as a sample and stored in a -80 °C refrigerator.
[0103] The T4 and IL-6 enzyme-linked immunosorbent assay kits (purchased from Jiangsu Enzyme Immunity Industry Co., Ltd.) were placed at 25°C for 30 min. The blank wells, standard wells and sample wells were set according to the instructions in the relevant manuals, and the concentrated washing solution and the standard were diluted, added, incubated and washed (the blank wells were added with enzyme-labeled reagents without incubation and washing). The color developer was added and mixed, and the mixture was incubated at 37°C in the dark for 15 min. The reaction was terminated with the stop solution, and the blank well was adjusted to zero. The absorbance OD value at a wavelength of 450 nm was quickly detected within 15 min.
[0104] According to the known concentration of the standard and the detected OD value, the linear regression equation was obtained using Excel software and the sample concentration was calculated. GraphPad Prism 8 software was used for statistical analysis. The results are shown in Table 4 and Fig.12 shown.
[0105] Table 4 Contents of T4 and IL-6 in the supernatant of thyroid follicular epithelial cells damaged by TgAb
[0106]
[0107] The results showed that the T4 level in the model group was lower than that in the control group, while the actual expression of IL-6 in the model group was significantly higher than that in the blank group, with a statistically significant difference of P<0.05. This indicated that TgAb treatment promoted the expression of inflammatory factors in thyroid follicular epithelial cells, induced inflammatory damage to thyroid follicular epithelial cells, and the cell model showed mild hypothyroidism.
[0108] In summary, TgAb can induce inflammatory damage such as proliferation inhibition, apoptosis, and growth inhibition in thyroid follicular epithelial cells Nthy-ori 3-1; through experiments, it was found that the inhibition of TgAb on the proliferation of thyroid follicular cells varies with time and antibody concentration, and the maximum inhibition rate can reach 80-90%. In the in vitro culture of monolayer cells without the formation of thyroid follicular functional structure, Tg is stored in thyroid follicular epithelial cells and has the ability to specifically bind to TgAb.
[0109] Example 10 Preparation of sesame seed composition liquid
[0110] Weigh 20g of Semen Semen, 12.5g of Radix Paeoniae Alba, 12.5g of Fructus Aurantii Immaturus, 25g of Radix Rhei, 3g of Cortex Magnoliae, and 10g of Apricot Kernel, mix them, place them in a clean beaker, add 600ml of ultrapure water and soak for 30min, place the beaker soaked with medicine on an electric stove covered with asbestos net and heat it until the water boils, then adjust to 200℃ and continue to decoct for 1h (during this period, stir the bottom of the beaker with a glass rod), collect the liquid medicine, add 200ml of ultrapure water and repeat the decoction, so that the remaining effective ingredients of the Chinese medicine slices can be precipitated as much as possible, combine the liquid medicine obtained by 2 decoctions, and concentrate it to a volume of 60ml at 85℃. Use four layers of gauze to cover the funnel, pour the liquid medicine on the top of the funnel, filter out impurities by negative pressure suction, and use a 50ml centrifuge tube to collect the remaining liquid medicine. Use a low-temperature high-speed centrifuge to centrifuge at 25°C and 3000r / min for 25min, pour the obtained supernatant into an evaporating dish and vacuum dry at 57°C and -0.093MPa for 24h, cover with plastic wrap, put the evaporating dish into a refrigerator and freeze at -75°C for 12h, transfer to a low-temperature freeze dryer, freeze-dry at -65°C for 43h to obtain a crystalline powder, crush it in the evaporating dish, scrape the powder into a 5ml EP tube, and place it in the refrigerator for later use.
[0111] Weigh 1 g of drug powder using an electronic balance and put it into a 1.5 ml EP tube. Add 0.25 ml of RPMI-1640 culture medium and vortex to mix. The drug concentration is 4000 μg / ml. Filter the drug solution through a 0.22 μm micropore bacterial filter membrane into a new 1.5 ml EP tube and store in a refrigerator.
[0112] Example 11 MTT experiment
[0113] Nthy-ori 3-1 cells were used as the experimental research object, and the effect of the hemp seed composition on the proliferation of Nthy-ori 3-1 cells under the condition of TgAb-induced Nthy-ori 3-1 cell damage was observed by MTT experiment, as follows:
[0114] The cells were treated according to the method in Example 1 to obtain a treated 96-well plate, and a model control group, a model drug administration group, a blank control group, and a blank drug administration group were set in the 96-well plate, and 3 rows of duplicate wells were set for each group; specifically, 100 μl / well of serum-free culture medium was added to the blank control group and the blank drug administration group; 100 μl / well of 8 ng / ml TgAb working solution diluted with RPMI-1640 culture medium was added to the model control group and the model drug administration group. After the working solution of each group has fully acted on the cells for 15 minutes, 100 μl / well serum-free medium is added to the blank control group and the model control group; 100 μl / well, 100 μg / ml of the hemp seed composition is added to the model administration group and the blank administration group, and the cells are placed in a cell culture incubator for 24 hours. After the 96-well plate is taken out and placed under a microscope for observation, it is transferred to a clean bench to discard the supernatant, and 100 μl of the pre-prepared 10% MTT working solution is added to each well, and the incubator is continued for 3.5 hours. The MTT solution is discarded, and 150 μl of DMSO solution is added to each well, and the crystal violet is moved to a horizontal shaker and shaken for 20 minutes to completely dissolve the crystal violet. The absorbance OD value at 570 nm is measured with an enzyme marker, and the experiment is repeated 3 times. The cell protection rate of each group under the action of a drug concentration of 100 μg / ml is calculated. The results are shown in Table 5.
[0115] The calculation formula is:
[0116] Blank medication group: drug protection rate = (blank medication group OD value - blank control group OD value) / blank control group OD value × 100%;
[0117] Model drug administration group: drug protection rate = (OD value of model drug administration group - OD value of model control group) / OD value of model control group × 100%;
[0118] The net protection rate of the model medication group = the drug protection rate of the model group - the drug protection rate of the blank group.
[0119] Table 5 Protection rate of sesame seed composition on cells
[0120]
[0121] The results showed that: for the sesame seed composition, the cell viability of the model administration group was better than that of the model control group (P<0.05), but lower than that of the blank control group; the cell viability of the blank administration group was different from that of the blank control group, but there was no significant change in viability; compared with the blank administration group, the cell activity protection effect of the model administration group was more obvious. That is, the sesame seed composition can improve the damage of TgAb to thyroid follicular epithelial cells.
[0122] Example 12 The dose-effect relationship of the sesame seed composition in relieving thyroid follicular epithelial cell damage The sesame seed composition with a crude drug concentration of 400 μg / ml was used as the initial value, and gradient dilution was performed in sequence. The experiment was carried out according to the method of Example 11, and the concentration curve of the drug dose effect was prepared using GraphPad Prism software. The results are shown in Table 6 and Fig.13 shown.
[0123] Table 6 The dose-effect relationship of different crude drug concentrations on the protective effect of thyroid follicular cell injury model
[0124]
[0125] The results showed that the sesame seed composition could alleviate the proliferation damage of thyroid follicular cells induced by TgAb. At the same time, the optimal drug concentration of the sesame seed composition was selected as 200 μg / ml based on the protection rate and net protection rate of the model administration group.
[0126] Example 13 Cell scratch test
[0127] Use a marker to mark two parallel lines on the bottom of each well of a 6-well plate and divide the bottom diameter equally. Subculture the Nthy-ori 3-1 cells cultured normally in Example 1 at a rate of 1×10 6 cells / well were inoculated into 6-well plates and cultured for 24 h to ensure that the cells covered 90% of the bottom of the dish. Each well was scratched with a 200 μl pipette tip, and the tip was evenly moved perpendicular to the thin line marked on the bottom of the dish. Each well was scratched twice. After scratching, the plates were washed twice with PBS to wash away the cells that fell off after mechanical damage.
[0128] A blank control group, a model control group and a model drug administration group were set up in a 6-well plate, wherein the blank control group was added with 500 μl of RPMI-1640 medium twice; the model control group was added with 500 μl / well of 8 ng / ml TgAb working solution obtained by diluting RPMI-1640 medium, and 500 μl / well of RPMI-1640 medium was added after the antibody acted for 15 minutes; the model drug administration group was first added with 500 μl of 8 ng / ml TgAb working solution diluted with RPMI-1640 medium, and after culturing for 15 minutes, 500 μl / well of sesame seed composition solution with a crude drug concentration of 200 μg / ml was added. The cell growth was observed at 0 and 24 hours of culture, and photographed and recorded, and the photographing position at each time point was tried to ensure that the scratch at the same location was taken, and the Image J software was used for analysis and calculation. The cell migration rate was calculated using the formula: cell migration rate = (blank group OD value - model group OD value) / blank group OD value × 100%. The results are shown in Fig.14 and Fig.15 shown.
[0129] The results showed that the wound healing rate of the model control group was 36.49±2.09%, and the wound healing rate of the model administration group added with the hemp seed composition was significantly reduced, and the difference was statistically significant (P<0.01). This shows that the hemp seed composition can alleviate the migration of damaged thyroid follicular cells, accelerate the disappearance of inflammation, and facilitate the development of tissue regeneration and repair.
[0130] Example 14 Observation of cell morphology using an inverted phase contrast microscope
[0131] The Nthy-ori 3-1 cells in the logarithmic growth phase in Example 1 were digested with 0.25% EDTA-containing trypsin solution (purchased from Sigma, USA). After counting the cells, the cells were diluted to a cell density of 5×10 5 After preparing a cell suspension of 50 cells / ml, the cells were inoculated into a 6-well plate and incubated in a carbon dioxide constant temperature incubator for 24 h. The supernatant in the plate was aspirated and the plate was washed twice with PBS solution.
[0132] A blank control group, a model control group, a model administration group, and a blank administration group were set up in a 6-well plate. Among them, 500 μl of RPMI-1640 culture medium was added to each well of the blank control group and the blank administration group; 500 μl of 8 ng / ml TgAb working solution diluted with RPMI-1640 culture medium was added to each well of the model control group and the model administration group. After 15 minutes of action, 500 μl of RPMI-1640 culture medium was continued to be added to each well of the blank control group and the model control group; 500 μl of sesame seed composition liquid with a crude drug concentration of 200 μg / ml was added to each well of the blank administration group and the model administration group. The 6-well plate was placed in a 37°C constant temperature incubator and continued to be cultured for 24 hours, and then transferred to an inverted phase contrast microscope to observe the morphological changes of the cells and magnified to 200 times for photographing and recording. The results are as follows Fig.16 , Fig.17 , Fig.18 shown.
[0133] The results showed that compared with the blank control group, the blank administration group with the addition of the hemp seed composition showed no significant changes in epithelial cell morphology, with clear cell boundaries and transparent cytoplasm. Compared with the model control group, the cell morphology of the model administration group with the addition of the hemp seed composition was more stretched and irregular. At the same time, compared with the blank administration group, the cell boundaries of the model administration group were unclear, the edges were blurred, the cytoplasm was less, there were bubble-like cell structure protrusions, and cell fragments were visible.
[0134] Example 15 Flow cytometry to measure cell model damage rate
[0135] The cell model injury rate was determined by the method in Example 7, except that a blank group (treatment method was the same as the blank control group in Example 14), a model group (treatment method was the same as the model control group in Example 14), and a model administration group (treatment method was the same as the model administration group in Example 14) were set in a 6-well plate. The results are shown in Tables 7 and Fig.19 , Fig. 20 and Fig.21 shown.
[0136] Table 7 Changes in cell model damage rate after the action of sesame seed composition
[0137]
[0138] Compared with the blank group, the cell apoptosis rate in the model group was significantly increased, indicating that TgAb did induce excessive apoptosis of thyroid follicular cells; compared with the blank group, the cell apoptosis rate in the model medication group did not change so significantly. The protective effect of the sesame seed composition on the TgAb-damaged thyroid follicular cell model may be partly due to the alleviation of cell apoptosis.
[0139] Example 16 Enzyme-linked immunosorbent assay
[0140] The experiment was conducted using the method in Example 8, except that a blank control group, a model control group, and a model administration group were set up in a 6-well plate (the treatment method of each group was the same as that of Example 14); the rest of the treatments were the same as those of Example 8. The results are shown in Tables 8 and Fig. 22 shown.
[0141] Table 8 ELISA method to detect the content of T4 and IL-6 in the cell supernatant after the action of the hemp seed composition
[0142]
[0143] ELISA test found that the supernatant content of T4 in the model administration group was higher than that in the model control group and lower than that in the blank control group; while the expression level of inflammatory factor IL-6 in the model administration group was lower than that in the model control group. This result shows that the hemp seed composition can alleviate the inflammatory damage caused by overexpression of inflammatory factor IL-6 in the thyroid follicular cell injury model and regulate the secretion level of T4.
[0144] In summary, the sesame seed composition can alleviate TgAb-induced cell proliferation inhibition, apoptosis, cell migration and overexpression of inflammatory factors, and can regulate thyroxine levels, laying a foundation for the study of the mechanism of thyroid damage and providing a therapeutic basis for the selection and application of traditional Chinese medicine in Hashimoto's thyroiditis.
[0145] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Application of a hemp seed composition in the preparation of a medicine for treating Hashimoto's thyroiditis.
2. The use according to claim 1, characterized in that: The hemp seed composition comprises the following raw material components in parts by weight: 20-25 parts of hemp seed kernel, 10-15 parts of peony root, 10-15 parts of immature bitter orange, 25-30 parts of rhubarb, 1-5 parts of magnolia bark, and 10-15 parts of apricot kernel.
3. The use according to claim 1, characterized in that: The crude drug concentration of the hemp seed composition is 180-220 μg / ml.
4. The use according to any one of claims 1 to 3, characterized in that: The preparation method of the hemp seed composition comprises the following steps: (1) mixing hemp seed, peony root, immature bitter orange, rhubarb, magnolia bark and apricot kernel with water, soaking, decocting, and obtaining a decoction 1 and a medicinal residue; (2) decocting the medicinal residue for a second time to obtain decoction 2; (3) combining decoction 1 and decoction 2, concentrating, vacuum drying, freezing, and freeze-drying to obtain a sesame seed composition.
5. The use according to claim 4, characterized in that: The amount of water used in step (1) is 7.5 to 10 times the amount of the medicinal material to be soaked.
6. The use according to claim 4, characterized in that: The solvent for the secondary decoction in step (2) is water, and the amount of water used is 2 to 3 times the mass of the medicinal residue.
7. The use according to claim 4, characterized in that: The concentration time in step (3) is based on obtaining 50 to 70 ml of concentrated solution.
8. The use according to claim 4, characterized in that: The freezing temperature in step (3) is -70 to -80°C, and the freezing time is 10 to 15 hours.
9. The use according to claim 8, characterized in that: The freeze-drying temperature of step (3) is -60 to -70°C, and the freeze-drying time is 36 to 48 hours.
10. Use of a sesame seed composition in the preparation of a medicine for treating thyroid cell damage.
